Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transfer Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113636968B details a novel Ru-catalyzed route for 3-acylpyrroles. Discover cost-effective, scalable manufacturing for pharmaceutical intermediates.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN113636968B details a novel Ru-catalyzed route for 3-acylpyrroles, offering cost-effective and scalable manufacturing solutions for pharmaceutical supply chains.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.
Patent CN110002952A reveals iridium-catalyzed transfer hydrogenation for high-purity alcohol synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Discover a novel synthesis method for Donepezil Hydrochloride featuring transfer hydrogenation and Jones oxidation. Achieve superior purity and yield for reliable pharmaceutical supply chains.
Patent CN110002952B reveals efficient iridium catalysis for alpha,beta-unsaturated alcohols, offering cost-effective pharma intermediate synthesis.
Novel Ru-catalyzed transfer hydrogenation method for 3-acylpyrroles. High atom economy, scalable process for reliable pharmaceutical intermediate supply and cost reduction.
Patent CN110483420B details a novel Rh-catalyzed reduction of quinoxalines using water as a hydrogen source, offering significant cost reduction and safer manufacturing for pharmaceutical intermediates.
Patent CN113636968B details a Ru-catalyzed route to 3-acylpyrroles. Offers cost reduction in API manufacturing and high atom economy for pharma intermediates.
Novel water-based hydrogenation method reduces costs and simplifies purification for high-purity tetrahydroquinoxaline pharmaceutical intermediates.
Patent CN113636968B details a Ru-catalyzed transfer hydrogenation route for 3-acylpyrroles, offering high atom economy and simplified purification for API intermediates.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.